Research organizations in Houston and San Antonio say they are eager to take advantage of the proposed fund championed by Lt.

While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to ...

Baylor College of Medicine's uncertainty over health research funding is prompting the school to scale back research and ...

A longtime public servant, Turner served in the Texas House of Representatives for many years before he was elected Houston’s ...

New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

PranaX Corporation ( an emerging regenerative medicine biotechnology company, today announced that it has licensed exosome technology from The University of Texas MD Anderson Cancer Center to develop ...

NTx founded a Scientific Advisory Board (SAB) with luminaries in oncology, cellular therapy, and immunology joining as ...

Tim Story, a Mississippi football coach, was given months to live after late-stage colon cancer. He enrolled in a clinical ...

A longtime public servant, Turner was Houston’s 62nd mayor from 2016 to 2024 before being elected to represent Texas’ 18th ...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence ...

Sylvester Turner became the 62nd mayor of Houston, leading the city from 2016 to 2024, before being elected to the United ...